Apricus Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.01.17	Gainers & Losers Of The Day: CATB, MCUR, BIOC, SSH, ZYNE… (RTTNews)
19.01.17	Hopeful of Reduced Regulation, Biotech Stocks Stay the Course with Advanced Drug Developments (PR Newswire)
19.01.17	DERM Delights With A Hat-trick, Shot In The Arm For APRI, FDA Nod For TEVA (RTTNews)
19.01.17	Gainers & Losers Of The Day: APRI, LIFE, JAZZ, ETRM, BIOC... (RTTNews)
13.01.17	Gainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI (RTTNews)
12.01.17	Gainers & Losers Of The Day: ACST, APRI, SBBP, NVDQ, NVCR (RTTNews)
11.01.17	Gainers & Losers Of The Day: BIOC, CUR, ONTX, EGLT, ABAX... (RTTNews)
27.12.16	Apricus Biosciences Launches Vitaros In Lebanon; Receives Milestone Payment (RTTNews)
08.12.16	Drug Makers Stocks Under Scanner -- Novo Nordisk, Synergy Pharma, Pernix Therapeutics, and Apricus Biosciences (PR Newswire)
01.12.16	Apricus Biosciences Gets Nasdaq Compliance Notice - Quick Facts (RTTNews)
21.11.16	TENX Awaits Data In Jan, GBIM Hit Hard, FDA Says No To SPPI (RTTNews)
08.11.16	EARNINGS SUMMARY: Details of Apricus Biosciences, Inc. Q3 Earnings Report (RTTNews)
06.09.16	Apricus' Partner Recordati Launches Vitaros In Portugal, Ireland And Poland (RTTNews)
15.08.16	Apricus Biosciences Transfers UK Marketing Authorization For Vitaros To Ferring (RTTNews)
04.08.16	EARNINGS SUMMARY: Details of Apricus Biosciences, Inc. Q2 Earnings Report (RTTNews)
25.07.16	Apricus, Sandoz To Terminate License For Vitaros; Expands Tie-up With Ferring (RTTNews)
09.05.16	EARNINGS SUMMARY: Details of Apricus Biosciences, Inc. Q1 Earnings Report (RTTNews)
07.04.16	BIND In A Fix, APRI To File NDA In Q3, TSRO Abuzz (RTTNews)
06.04.16	Apricus Biosciences Announces 30% Cut In Staff, Operating Expenses (RTTNews)
29.03.16	ALDR Gains As Pain Wanes, APRI Disappoints, PBYI's NDA Filing Delayed Yet Again (RTTNews)
28.03.16	Apricus To Discontinue Fispemifene In Symptomatic Secondary Hypogonadism (RTTNews)
10.03.16	It's One Up For AKBA, CYNA Under Close Watch, Busy Days Ahead For APRI (RTTNews)
09.03.16	EARNINGS SUMMARY: Details of Apricus Biosciences, Inc. Q4 Earnings Report (RTTNews)
06.01.16	Apricus Biosciences Expects To Report Top-line Data For Fispemifene In Q1 (RTTNews)
05.11.15	EARNINGS SUMMARY: Details of Apricus Biosciences, Inc. Q3 Earnings Report (RTTNews)
29.10.15	GILD Files NDA For HCV Medicine, Canada Gets MonaLisa Touch, APRI Awaits Data (RTTNews)
01.10.15	Ferring Pharma Signs Deal With Apricus To Commercialize Vitaros - Quick Facts (RTTNews)
18.09.15	CANF Making Big Move, TGTX And FDA On The Same Page For CLL Trial, APRI On Watch (RTTNews)
05.08.15	EARNINGS SUMMARY: Details of Apricus Biosciences, Inc. Q2 Earnings Report (RTTNews)
16.06.15	AERI Rockets On FDA Feedback, ADXS On The Job, ITCI To Report Trial Data In Q3 (RTTNews)
16.03.15	Apricus Biosciences Q4 Loss Widens - Quick Facts (RTTNews)
04.02.15	AMGN's Biosimilar Matches Blockbuster, PFE Gets FDA Nod, LGND Does A Deal (RTTNews)
28.01.15	ABMD Posts Stellar Results, HNSN Rallies, STJ Gets FDA Nod, Watch Out For VBLT (RTTNews)
23.12.14	Apricus Announces Plans To Further Commercialize Its ED Drug Vitaros In 2015 (RTTNews)
02.12.14	Apricus Biosciences Names Brian Dorsey Chief Development Officer (RTTNews)
20.10.14	Apricus Licenses US Rights For Fispemifene From Forendo Pharma (RTTNews)
08.08.14	Apricus Biosciences Signs Partnership With Scleroderma Research Foundation (RTTNews)
07.10.13	Apricus Biosciences Gets National Phase Approval For ED Cream Vitaros In Germany (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Apricus Biosciences Inc

Aktien Top/Flop

Meistgelesene Nachrichten